Tech Company M&A Transactions
Ferrokin BioSciences Acquisition
Headquartered in San Carlos, Ferrokin BioSciences was acquired by Shire Pharmaceuticals. Shire Pharmaceuticals said the transaction price was $325 million.
Transaction Overview
Company Name
Acquired By
Announced On
3/15/2012
Transaction Type
M&A
Amount
$325,000,000
M&A Terms
Shire has signed an agreement to acquire FerroKin BioSciences, Inc., for an upfront payment of $100 million, payable in cash at closing, plus potential post-closing milestone payments of up to $225 million, depending upon the achievement of certain clinical development, regulatory and net sales targets.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
2729 Debbie Court
San Carlos, CA 94070
USA
San Carlos, CA 94070
USA
Phone
Website
Email Address
Not Recorded
Overview
FerroKin BioSciences is a clinical stage biotechnology company based in the San Francisco Bay Area and focused on developing chelation therapies for a broad range of clinical indications.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Hugh Rienhoff
Browse more venture capital transactions:
Prev: 3/14/2012: Adaptive Insights venture capital transaction
Next: 3/15/2012: LUMEnergi venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs